The inaugural Genetic Agency Technology Conference (GATC) on November 11th, 2025 will convene technical thought leaders, gene therapy developers, patients, their families, and patient advocates across ...

Genetic Technologies (AU:GTG) has released an update. Genetic Technologies Limited has partnered with Stayhealthy, Inc. to distribute Stayhealthy’s Multi-Risk Test across North America, marking a ...

With a new generation of fast and affordable gene sequencers, researchers are better equipped than ever to tackle Earth’s ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...

Gene editing is now reaching the mainstream, ushering in a new era of genetic manipulation. Traditionally, inserting or deleting entire genes, regulating their expression, and altering specific ...

Genetic Technologies (NASDAQ:GENE) stock tumbled 26% in afternoon trading Thursday after the genomics-based test developer announced a $2M registered direct offering. Shares of Genetic Technologies ...

The rollout of a type of genetic technology called a gene drive for tackling malaria could be edging closer after a lab study ...

DALLAS--(BUSINESS WIRE)--Colossal Biosciences, a breakthrough biosciences and genetic engineering company, announced an oversubscribed $60M Series A financing led by Thomas Tull and At One Ventures ...

Nearly 80% of people in Australia and the U.S. that used Genetic Technologies Ltd.’s Genetype multi-risk assessment test showed an elevated risk for at least one disease covered by the test.

Genetic Technologies (NASDAQ:GENE) said Friday its June-quarter receipts were A$2.1 million. At the end of June 2023, the company had A$7.9 million in cash and cash equivalents. Cash receipts from ...